Call Us: 1.800.873.5297


Testosterone Drugs – Increased Risk of Blood Clots, Heart Attack, & Stroke

Recent studies have shown that dangerous blood clots can occur as early as one month and up to the first 90 days after starting testosterone therapy. The risk of heart attack for men over 65 has nearly doubled. A risk for serious or fatal complications for men under 65 years of age with pre-existing heart […]


Organizations Urge FDA to Reverse its Approval of Prescription Painkiller Zohydro ER

A recent article published in the British Medical Journal on March 3, 2014 reports that over 40 consumer groups, addiction treatment organizations, and healthcare agencies have called on the United States Food and Drug Administration (FDA) to reverse its recent approval of a potent oral opioid drug they say threatens to worsen a widespread addiction […]


Transvaginal Mesh Product Manufacturer Coloplast Agrees to $16 Million Settlement

Bloomberg News reports that Colplast A/S, the manufacturer of, has agreed to pay approximately $16 million to settle lawsuits alleging that its vaginal mesh products have injured women. The article details that Coloplast officials agreed in January to resolve approximately 400 lawsuits, although the official was not identified as they were not authorized to publicly […]


Playtex Announces Voluntary Recall of AC/DC Power Adapters for Electric Breast Pump Due to Risk of Electric Shock

On March 18, 2014, Playtex Manufacturing, Inc. issued a press release announcing a voluntary nationwide recall of certain AC/DC power adapters used with the Playtex® Nurser Deluxe Double Electric Breast Pump. The Playtex® Nurser Deluxe Double Electric Breast Pump has been sold across the nation and is available online and with specialty retailers. Playtex urges […]


New Study Reports that Infant “Sleep Machines” May Actually Harm Hearing

The New York Times reported on a recent study that supports that “sleep machines” used for infants can be loud enough at maximum volume to damage a baby’s hearing. The devices use a constant sound, such as “white noise” or calming nature sounds, to help infants fall asleep and stay asleep. These machines, often embedded […]


Pradaxa® MDL Lawsuit Update (MDL 2385): First Pradaxa® Trial Now Set to Begin September 2014

The first trial in the Pradaxa® Multidistrict Litigation entitled In re: Pradaxa® (Dabigatran Etexilate) Products Liability Litigation (MDL 2385, Case No. 12-md-2385) is set to begin this fall in the United States District Court for the Southern District of Illinois. According to a recent Case Management Order issued by The Honorable Chief Judge David R. […]


NuvaRing® MDL Lawsuit Update (MDL 1964): NuvaRing® Settlement Opt-In Deadline Extended Until March 25

On February 7, 2014, United States District Court Judge Rodney W. Sippel approved a $100 Million settlement in the NuvaRing® Multidistrict Litigation In re: NuvaRing® Products Liability Litigation (MDL No. 1964, Case No. 08-md-1964). The terms of the settlement require that at least 95% of eligible claimants opt into the settlement program. “The deadline for […]


FDA Issues Class I Recall for GE Healthcare Resuscitation Systems

On February 28, 2014, the FDA issued a Class I Recall for GE Healthcare Resuscitation Systems with the issue being that “the oxygen and air wall inlet fittings on the back panel of the resuscitation systems were reversed during assembly.” The FDA warned that “[t]hese recalled products may interfere with oxygen delivery, resulting in inaccurate […]


Testosterone Drugs Cause Heart Attacks, Strokes, and Blood Clots, New Lawsuits Claim

According to five lawsuits recently filed in the United States District Court for the Northern District of Illinois, the Testosterone replacement drug, AndroGel, is allegedly linked to causing serious medical problems, including life threatening heart attacks, strokes, and blood clots. The cases are Aurecchia v. AbbVie, Case No. 14-cv-00772; Benn v. AbbVie, Case No. 14-cv-00774; […]


Safety Advisory Issued by Thoratec Corporation for HeartMate II LVAS Pocket System Controller After 4 Patient Deaths

On March 5, 2014, the FDA reported that “Thoratec Corporation issued a safety advisory because some patients and caregivers have experienced difficulties with the process of changing from a primary system controller to their backup system controller. These difficulties have resulted in four deaths and five reports of loss of consciousness or other symptoms of […]

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.